Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of ADENUIRC is substantial. |
Clinical Added Value
| minor |
The Transparency Committee considers that ADENURIC provides a minor improvement in actual benefit (level IV) in the management of symptomatic chronic hyperuricaemia compared to the current therapeutic strategy based on allopurinol. |
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
cfAV06U9ucQUR2c3
